Following the Use of Gel Prosethetics in Breast Reconstruction
Core Gel Study of the Safety and Effectiveness of Mentor Round Low Bleed Gel-filled Mammary Prostheses in Patients Who Are Undergoing Primary Breast Reconstruction or Revision
Sponsor: Mentor Worldwide, LLC
Listed as NCT00585884, this observational or N/A phase trial focuses on Breast Cancer and remains completed. Sponsored by Mentor Worldwide, LLC, it has been updated 11 times since 2001, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Sep 2023 — Jul 2024 [monthly]
Completed
-
May 2023 — Sep 2023 [monthly]
Completed
-
Feb 2021 — May 2023 [monthly]
Completed
Status: Active Not Recruiting → Completed
▶ Show 6 earlier versions
-
Jan 2021 — Feb 2021 [monthly]
Active Not Recruiting
-
Nov 2018 — Jan 2021 [monthly]
Active Not Recruiting
-
Jun 2018 — Nov 2018 [monthly]
Active Not Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Active Not Recruiting
Phase: NA → None
-
Feb 2017 — Apr 2018 [monthly]
Active Not Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting NA
First recorded
Feb 2001
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Mentor Worldwide, LLC
- University of California, Irvine
For direct contact, visit the study record on ClinicalTrials.gov .